Literature DB >> 29731890

Solanine induced apoptosis and increased chemosensitivity to Adriamycin in T-cell acute lymphoblastic leukemia cells.

Ying-Jie Yi1, Xiu-Hong Jia1, Jian-Yong Wang1, Jie-Ru Chen1, Hong Wang1, You-Jie Li2.   

Abstract

Solanine is an alkaloid and is the main extract of the traditional Chinese herb, Solanum nigrum Linn. It has been reported that Solanine has anti-inflammatory and antitumor properties. The present study aimed to investigate the antitumor effect of Solanine in Jurkat cells and demonstrate the molecular mechanism of antitumor activity of Solanine. A Cell Counting Kit-8 assay demonstrated that Solanine inhibited the proliferation of Jurkat cells in a dose-and time-dependent manner. Cell apoptosis was measured by flow cytometry. Flow cytometry revealed that Solanine induced apoptosis in a dose-dependent manner in Jurkat cells. Reverse transcription-quantitative polymerase chain reaction demonstrated that Solanine modulated the mRNA levels of B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax). Additionally, Bcl-2 and Bax expression was measured using western blot analysis. Western blot analysis revealed a significant increase in the expression of Bax and decrease in the expression of Bcl-2. Solanine increased the chemosensitivity of Jurkat cells to Adriamycin. In summary, the present results indicated that the antitumor activity of Solanine was associated with inhibition of cell proliferation, induction of apoptosis and increasing cytotoxicity of Adriamycin. Therefore, Solanine may have potential as a novel agent for the treatment of acute lymphocytic leukemia.

Entities:  

Keywords:  Jurkat cell; Solanine; apoptosis; chemosensitivity

Year:  2018        PMID: 29731890      PMCID: PMC5920823          DOI: 10.3892/ol.2018.8229

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Chemistry and anticarcinogenic mechanisms of glycoalkaloids produced by eggplants, potatoes, and tomatoes.

Authors:  Mendel Friedman
Journal:  J Agric Food Chem       Date:  2015-03-30       Impact factor: 5.279

Review 3.  Novel biological insights in T-cell acute lymphoblastic leukemia.

Authors:  Kaat Durinck; Steven Goossens; Sofie Peirs; Annelynn Wallaert; Wouter Van Loocke; Filip Matthijssens; Tim Pieters; Gloria Milani; Tim Lammens; Pieter Rondou; Nadine Van Roy; Barbara De Moerloose; Yves Benoit; Jody Haigh; Frank Speleman; Bruce Poppe; Pieter Van Vlierberghe
Journal:  Exp Hematol       Date:  2015-06-26       Impact factor: 3.084

4.  Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.

Authors:  Lamprini Stamati; Margaritis Avgeris; Helen Kosmidis; Margarita Baka; Theodora Anastasiou; Despina Piatopoulou; Andreas Scorilas; Dimitrios Gourgiotis
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-16       Impact factor: 4.553

5.  Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells.

Authors:  Mendel Friedman; Kap-Rang Lee; Hyun-Jeong Kim; In-Seon Lee; Nobuyuke Kozukue
Journal:  J Agric Food Chem       Date:  2005-07-27       Impact factor: 5.279

6.  Anti-inflammatory properties of potato glycoalkaloids in stimulated Jurkat and Raw 264.7 mouse macrophages.

Authors:  Olivia M Kenny; Catherine M McCarthy; Nigel P Brunton; Mohammad B Hossain; Dilip K Rai; Stuart G Collins; Peter W Jones; Anita R Maguire; Nora M O'Brien
Journal:  Life Sci       Date:  2013-02-20       Impact factor: 5.037

7.  Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.

Authors:  Anuradha Cingeetham; Sugunakar Vuree; Nageswara Rao Dunna; Manjula Gorre; Santhoshi Rani Nanchari; Prajitha Mohandas Edathara; Phannibhushann Meka; Sandhya Annamaneni; Raghunadharao Digumarthi; Sudha Sinha; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2015-05-10

8.  Bax monomers form dimer units in the membrane that further self-assemble into multiple oligomeric species.

Authors:  Yamunadevi Subburaj; Katia Cosentino; Markus Axmann; Esteban Pedrueza-Villalmanzo; Eduard Hermann; Stephanie Bleicken; Joachim Spatz; Ana J García-Sáez
Journal:  Nat Commun       Date:  2015-08-14       Impact factor: 14.919

9.  Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.

Authors:  Shuping Wang; Min Zhou; Jian Ouyang; Zhirong Geng; Zhilin Wang
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

10.  EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches.

Authors:  V D'Angelo; A Iannotta; M Ramaglia; A Lombardi; M R Zarone; V Desiderio; M C Affinita; G Pecoraro; M Di Martino; P Indolfi; F Casale; M Caraglia
Journal:  J Exp Clin Cancer Res       Date:  2015-08-14
View more
  3 in total

1.  α-Solanine Causes Cellular Dysfunction of Human Trophoblast Cells via Apoptosis and Autophagy.

Authors:  Zhilong Chen; Chen Li; Anwen Yuan; Ting Gu; Feng Zhang; Xiujun Fan; Xiaosong Wu; Xingyao Xiong; Qing Yang
Journal:  Toxins (Basel)       Date:  2021-01-18       Impact factor: 4.546

Review 2.  A narrative review of the antitumor studies of solanine.

Authors:  Shan Luo; Guo-Jiang Tian; Fu-Xiang Yu; Zheng-De Wen
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

Review 3.  Hidden in Plants-A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies.

Authors:  Tomasz Kowalczyk; Anna Merecz-Sadowska; Patricia Rijo; Mattia Mori; Sophia Hatziantoniou; Karol Górski; Janusz Szemraj; Janusz Piekarski; Tomasz Śliwiński; Michał Bijak; Przemysław Sitarek
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.